{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:58:58Z","timestamp":1792025938230,"version":"4.4.0"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which initially surfaced in late 2019, often triggers severe pulmonary complications, encompassing various disease mechanisms such as intense lung inflammation, vascular dysfunction, and pulmonary embolism. Currently, however, there\u2019s no drug addressing all these mechanisms simultaneously. This study explored the multi-targeting potential of S-nitrosoglutathione (GSNO) and N6022, an inhibitor of GSNO reductase (GSNOR) on markers of inflammatory, vascular, and thrombotic diseases related to COVID-19-induced acute lung disease. For this, acute lung disease was induced in C57BL\/6 mice through intranasal administration of recombinant SARS-CoV-2 spike protein S1 domain (SP-S1). The mice exhibited fever, body weight loss, and increased blood levels and lung expression of proinflammatory cytokines (e.g., TNF-\u03b1 and IL-6) as well as increased vascular inflammation mediated by ICAM-1 and VCAM-1 and lung infiltration by immune cells (e.g., neutrophils, monocytes, and activated cytotoxic and helper T cells). Further, the mice exhibited increased lung hyperpermeability (lung Evans blue extravasation) leading to lung edema development as well as elevated blood coagulation factors (e.g., fibrinogen, thrombin, activated platelets, and von Willebrand factor) and lung fibrin deposition. Similar to the patients with COVID-19, male mice showed more severe disease than female mice, along with higher GSNOR expression in the lungs. Optimization of GSNO by treatment with exogenous GSNO or inhibition of GSNOR by N6022 (or GSNO knockout) protects against SP-S1-induced lung diseases in both genders. These findings provide evidence for the potential efficacies of GSNO and GSNOR inhibitors in addressing the multi-mechanistic nature of SARS-CoV-2 SP-associated acute-lung disease.<\/jats:p>","DOI":"10.3389\/fphar.2023.1304697","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T06:58:08Z","timestamp":1702018688000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice"],"prefix":"10.3389","volume":"14","author":[{"given":"Judong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avtar K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeseong","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inderjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/jth.13738","article-title":"cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway","volume":"15","author":"Aburima","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"B2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/1097-0142(197411)34:5<1727::aid-cncr2820340522>3.0.co;2-y","article-title":"Urinary cholesterol. IV. Its excretion in women with neoplasms of the genital system","volume":"37","author":"Acevedo","year":"1971","journal-title":"Obstet. Gynecol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"957224","DOI":"10.3389\/fimmu.2022.957224","article-title":"SARS-CoV-2 modulates virus receptor expression in placenta and can induce trophoblast fusion, inflammation and endothelial permeability","volume":"13","author":"Agostinis","year":"2022","journal-title":"Front. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2009.09.007","article-title":"Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected","volume":"395","author":"Akerstrom","year":"2009","journal-title":"Virology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1128\/JVI.79.3.1966-1969.2005","article-title":"Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus","volume":"79","author":"Akerstrom","year":"2005","journal-title":"J. Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajem.2020.09.065","article-title":"Thrombotic complications of COVID-19","volume":"39","author":"Avila","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2011-0392TR","article-title":"Role of chemokines in the pathogenesis of acute lung injury","volume":"46","author":"Bhatia","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B8","article-title":"SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-beta signaling","author":"Biering","year":"2021"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2100377","DOI":"10.1183\/13993003.00377-2021","article-title":"Between inflammation and thrombosis: endothelial cells in COVID-19","volume":"58","author":"Birnhuber","year":"2021","journal-title":"Eur. Respir. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2466-14-3","article-title":"Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB\/c mice through attenuation of both bronchoconstriction and inflammation","volume":"14","author":"Blonder","year":"2014","journal-title":"BMC Pulm. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/microorganisms9091820","article-title":"TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection","volume":"9","author":"Bortolotti","year":"2021","journal-title":"Microorganisms"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1111\/bph.14644","article-title":"S-nitrosoglutathione inhibits cerebrovascular angiotensin II-dependent and -independent AT(1) receptor responses: a possible role of S-nitrosation","volume":"176","author":"Bouressam","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1089\/ars.2012.4590","article-title":"The chemical biology of S-nitrosothiols","volume":"17","author":"Broniowska","year":"2012","journal-title":"Antioxid. Redox Signal"},{"key":"B15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12967-020-02333-9","article-title":"Anti-IL6R role in treatment of COVID-19-related ARDS","volume":"18","author":"Buonaguro","year":"2020","journal-title":"J. Transl. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e21801","DOI":"10.1096\/fj.202002742RR","article-title":"Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice","volume":"35","author":"Cao","year":"2021","journal-title":"Faseb J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/s41598-021-83831-8","article-title":"Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units","volume":"11","author":"Carubbi","year":"2021","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/CIRCRESAHA.118.313956","article-title":"S-nitrosoglutathione reductase is essential for protecting the female heart from ischemia-reperfusion injury","volume":"123","author":"Casin","year":"2018","journal-title":"Circ. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/bbrc.1998.9130","article-title":"Inhibition of clotting factor XIII activity by nitric oxide","volume":"249","author":"Catani","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6615787","DOI":"10.1155\/2021\/6615787","article-title":"Predicting severity and intrahospital mortality in COVID-19: the place and role of oxidative stress","volume":"2021","author":"Cekerevac","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"B21","first-page":"303","article-title":"The age-related characteristics in the regulation of intraocular pressure in monkeys","volume":"5","author":"Chanchikov","year":"1990","journal-title":"Oftalmol. Zh"},{"key":"B22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.niox.2018.12.007","article-title":"Regulation of endothelial barrier integrity by redox-dependent nitric oxide signaling: implication in traumatic and inflammatory brain injuries","volume":"83","author":"Choi","year":"2019","journal-title":"Nitric Oxide"},{"key":"B23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.yrtph.2011.12.012","article-title":"A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma","volume":"62","author":"Colagiovanni","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"L477","DOI":"10.1152\/ajplung.00223.2021","article-title":"The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in \u039a18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells","volume":"321","author":"Colunga Biancatelli","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in Covid-19: a systematic review and meta-analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e28568","DOI":"10.1002\/jmv.28568","article-title":"Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19","volume":"95","author":"Craddock","year":"2023","journal-title":"J. Med. Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J. Hum. Hypertens."},{"key":"B28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/cvr\/28.5.691","article-title":"Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation","volume":"28","author":"De Belder","year":"1994","journal-title":"Cardiovasc Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/antiox8090404","article-title":"S-nitrosylation: an emerging paradigm of redox signaling","volume":"8","author":"Fernando","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","article-title":"Risk factors for severe and critically ill COVID-19 patients: a review","volume":"76","author":"Gao","year":"2021","journal-title":"Allergy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/mi.3.5.253","article-title":"S-nitrosylation signaling in cell biology","volume":"3","author":"Gaston","year":"2003","journal-title":"Mol. Interv."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9759735","DOI":"10.1155\/2017\/9759735","article-title":"Markers and biomarkers of endothelium: when something is rotten in the state","volume":"2017","author":"Goncharov","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"101201","DOI":"10.1016\/j.arr.2020.101201","article-title":"Does eNOS derived nitric oxide protect the young from severe COVID-19 complications?","volume":"64","author":"Guan","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.niox.2021.04.003","article-title":"Implications of SARS-Cov-2 infection on eNOS and iNOS activity: consequences for the respiratory and vascular systems","author":"Guimar\u00e3es","year":"2021","journal-title":"Nitric Oxide"},{"key":"B35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1172\/JCI62854","article-title":"S-nitrosylation: integrator of cardiovascular performance and oxygen delivery","volume":"123","author":"Haldar","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10787-020-00773-9","article-title":"The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients","volume":"29","author":"Hariharan","year":"2021","journal-title":"Inflammopharmacology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"680134","DOI":"10.3389\/fimmu.2021.680134","article-title":"Neutrophils and COVID-19: active participants and rational therapeutic targets","volume":"12","author":"Hazeldine","year":"2021","journal-title":"Front. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1097\/01.CCM.0000057846.21303.AB","article-title":"Coagulation, fibrinolysis, and fibrin deposition in acute lung injury","volume":"31","author":"Idell","year":"2003","journal-title":"Crit. Care Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"104836","DOI":"10.1016\/j.micpath.2021.104836","article-title":"Contribution of STAT3 to the pathogenesis of COVID-19","volume":"154","author":"Jafarzadeh","year":"2021","journal-title":"Microb. Pathog."},{"key":"B42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-020-00454-7","article-title":"Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1242\/jcs.03361","article-title":"Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2","volume":"120","author":"Kang-Decker","year":"2007","journal-title":"J. Cell Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1161\/01.cir.103.19.2371","article-title":"L-arginine and S-nitrosoglutathione reduce embolization in humans","volume":"103","author":"Kaposzta","year":"2001","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1161\/01.cir.0000041251.07332.28","article-title":"S-nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty","volume":"106","author":"Kaposzta","year":"2002","journal-title":"Circulation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijid.2004.04.012","article-title":"Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound","volume":"8","author":"Keyaerts","year":"2004","journal-title":"Int. J. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3389\/fimmu.2015.00635","article-title":"The immune system is a natural target for estrogen action: opposing effects of estrogen in two prototypical autoimmune diseases","volume":"6","author":"Khan","year":"2015","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1471-4159.2012.07947.x","article-title":"The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke","volume":"123","author":"Khan","year":"2012","journal-title":"J. Neurochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.jcbfm.9600012","article-title":"S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke","volume":"25","author":"Khan","year":"2005","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e68563","DOI":"10.7554\/eLife.68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway","volume":"10","author":"Khan","year":"2021","journal-title":"Elife"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1076029620962853","DOI":"10.1177\/1076029620962853","article-title":"COVID-19 and hypercoagulability: a review","volume":"26","author":"Kichloo","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"B52","doi-asserted-by":"publisher","first-page":"102053","DOI":"10.1016\/j.redox.2021.102053","article-title":"Regulation of B cell functions by S-nitrosoglutathione in the EAE model","volume":"45","author":"Kim","year":"","journal-title":"Redox Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/v13102021","article-title":"Spike proteins of SARS-CoV-2 induce pathological changes in molecular delivery and metabolic function in the brain endothelial cells","volume":"13","author":"Kim","year":"","journal-title":"Viruses"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1089\/ars.2013.5223","article-title":"STAT3 regulation by S-nitrosylation: implication for inflammatory disease","volume":"20","author":"Kim","year":"2014","journal-title":"Antioxid. Redox Signal"},{"key":"B55","doi-asserted-by":"publisher","first-page":"720109","DOI":"10.3389\/fimmu.2021.720109","article-title":"Monocytes and macrophages in COVID-19","volume":"12","author":"Knoll","year":"2021","journal-title":"Front. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/cvr\/cvaa097","article-title":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19","volume":"116","author":"Kreutz","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.3390\/v13112209","article-title":"SARS-CoV-2 spike protein S1-mediated endothelial injury and pro-inflammatory state is amplified by dihydrotestosterone and prevented by mineralocorticoid antagonism","volume":"13","author":"Kumar","year":"2021","journal-title":"Viruses"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","article-title":"SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2","volume":"128","author":"Lei","year":"2021","journal-title":"Circ. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cardiores.2007.03.024","article-title":"Nitric oxide regulation of protein trafficking in the cardiovascular system","volume":"75","author":"Lowenstein","year":"2007","journal-title":"Cardiovasc Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/jmv.27405","article-title":"Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19","volume":"94","author":"Manik","year":"2022","journal-title":"J. Med. Virol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/cpm.0000000000000381","article-title":"Corticosteroids for COVID-19-associated ARDS","volume":"27","author":"Marmor","year":"2020","journal-title":"Clin. Pulm. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1183\/09031936.00042414","article-title":"Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity","volume":"45","author":"Marozkina","year":"2015","journal-title":"Eur. Respir. J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1021\/bi002239y","article-title":"Inhibition of NF-kappa B by S-nitrosylation","volume":"40","author":"Marshall","year":"2001","journal-title":"Biochemistry"},{"key":"B66","doi-asserted-by":"publisher","first-page":"824851","DOI":"10.3389\/fcell.2022.824851","article-title":"COVID-19 and the vasculature: current aspects and long-term consequences","volume":"10","author":"Martinez-Salazar","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1038\/s41418-020-00633-7","article-title":"An aberrant STAT pathway is central to COVID-19","volume":"27","author":"Matsuyama","year":"2020","journal-title":"Cell Death Differ."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1093\/nar\/24.12.2236","article-title":"Inhibition of NF-kappaB DNA binding by nitric oxide","volume":"24","author":"Matthews","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/SHK.0000000000001660","article-title":"COVID-19 associated hypercoagulability: manifestations, mechanisms, and management","volume":"55","author":"Mazzeffi","year":"2021","journal-title":"Shock"},{"key":"B70","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jchf.2020.03.004","article-title":"COVID-19 illness and heart failure: a missing link?","volume":"8","author":"Mehra","year":"2020","journal-title":"JACC Heart Fail"},{"key":"B71","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41584-020-0474-5","article-title":"Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications","volume":"16","author":"Merrill","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"174306","DOI":"10.1016\/j.ejphar.2021.174306","article-title":"Effects of antiviral drug therapy on dynamic thiol\/disulphide homeostasis and nitric oxide levels in COVID-19 patients","volume":"907","author":"Mete","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1165\/rcmb.2013-0086MA","article-title":"Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung","volume":"49","author":"Misharin","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1161\/01.cir.98.14.1372","article-title":"S-nitrosoglutathione reduces the rate of embolization in humans","volume":"98","author":"Molloy","year":"1998","journal-title":"Circulation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"103893","DOI":"10.1016\/j.ebiom.2022.103893","article-title":"Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients","volume":"77","author":"Montiel","year":"2022","journal-title":"EBioMedicine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s11481-009-9187-x","article-title":"S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis","volume":"5","author":"Nath","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"717587","DOI":"10.3389\/fcell.2021.717587","article-title":"Developing cytokine storm-sensitive therapeutic strategy in COVID-19 using 8P9R chimeric peptide and soluble ACE2","volume":"9","author":"Nazerian","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.virusres.2014.03.013","article-title":"Role of pattern recognition receptors in flavivirus infections","volume":"185","author":"Nazmi","year":"2014","journal-title":"Virus Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e1011206","DOI":"10.1371\/journal.ppat.1011206","article-title":"Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range","volume":"19","author":"Ni","year":"2023","journal-title":"PLoS Pathog."},{"key":"B80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/medsci10010003","article-title":"Nitric oxide: the missing factor in COVID-19 severity?","volume":"10","author":"Nikolaidis","year":"2021","journal-title":"Med. Sci. (Basel)"},{"key":"B81","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41589-022-01149-6","article-title":"Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection","volume":"19","author":"Oh","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"B82","doi-asserted-by":"crossref","DOI":"10.1101\/2022.04.05.487060","article-title":"Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection","author":"Oh","year":"2022"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e14726","DOI":"10.14814\/phy2.14726","article-title":"SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation","volume":"9","author":"Ostergaard","year":"2021","journal-title":"Physiol. Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.4049\/jimmunol.2100144","article-title":"Selective inhibition of the interaction between SARS-CoV-2 spike S1 and ACE2 by SPIDAR peptide induces anti-inflammatory therapeutic responses","volume":"207","author":"Paidi","year":"","journal-title":"J. Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11481-020-09979-8","article-title":"ACE-2-interacting domain of SARS-CoV-2 (AIDS) peptide suppresses inflammation to reduce fever and protect lungs and heart in mice: implications for COVID-19 therapy","volume":"16","author":"Paidi","year":"","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e065781","DOI":"10.1002\/alz.065781","article-title":"Selective inhibition of ACE-2-interacting domain of SARS-CoV-2 by AIDS peptide attenuates Spike S1 associated behavioral and neuronal inflammation in in vitro and in vivo models","volume":"18","author":"Paidi","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B87","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1038\/s41598-023-38382-5","article-title":"SARS-CoV-2 spike protein induces lung endothelial cell dysfunction and thrombo-inflammation depending on the C3a\/C3a receptor signalling","volume":"13","author":"Perico","year":"2023","journal-title":"Sci. Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.chest.2021.06.016","article-title":"Pulmonary thrombosis and thromboembolism in COVID-19","volume":"160","author":"Poor","year":"2021","journal-title":"Chest"},{"key":"B89","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13293-020-00330-7","article-title":"Sex differences in severity and mortality from COVID-19: are males more vulnerable?","volume":"11","author":"Pradhan","year":"2020","journal-title":"Biol. Sex. Differ."},{"key":"B90","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/glia.20436","article-title":"GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions","volume":"55","author":"Prasad","year":"2007","journal-title":"Glia"},{"key":"B91","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1164\/rccm.200901-0158OC","article-title":"S-nitrosoglutathione reductase: an important regulator in human asthma","volume":"180","author":"Que","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cytogfr.2020.08.002","article-title":"Glycogen synthase kinase-3: a putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic","volume":"58","author":"Rana","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"B93","doi-asserted-by":"publisher","first-page":"8945","DOI":"10.1073\/pnas.0400588101","article-title":"Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation","volume":"101","author":"Reynaert","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.3390\/jcm11112951","article-title":"Cytokine profiles as potential prognostic and therapeutic markers in SARS-CoV-2-induced ARDS","volume":"11","author":"Salton","year":"2022","journal-title":"J. Clin. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1111\/jphp.12608","article-title":"S-Nitrosoglutathione ameliorates acute renal dysfunction in a rat model of lipopolysaccharide-induced sepsis","volume":"68","author":"Samuvel","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.freeradbiomed.2018.04.558","article-title":"S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis","volume":"121","author":"Saxena","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e1350","DOI":"10.1002\/cti2.1350","article-title":"Endothelial cells are not productively infected by SARS-CoV-2","volume":"10","author":"Schimmel","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B100","doi-asserted-by":"publisher","first-page":"CD010966","DOI":"10.1002\/14651858.CD010966.pub3","article-title":"Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)","volume":"12","author":"Southern","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cca.2020.07.046","article-title":"COVID-19 infection and thrombosis","volume":"510","author":"Srivastava","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.7861\/clinmed.2020-0146","article-title":"The renin-angiotensin system - a therapeutic target in COVID-19?","volume":"20","author":"Sturrock","year":"2020","journal-title":"Clin. Med. (Lond)"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s12035-021-02696-0","article-title":"Could SARS-CoV-2 spike protein Be responsible for long-COVID syndrome?","volume":"59","author":"Theoharides","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3390\/antiox11081609","article-title":"Molecular mechanisms related to responses to oxidative stress and antioxidative therapies in COVID-19: a systematic review","volume":"11","author":"Tsermpini","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1155\/S1110724304402034","article-title":"Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology","volume":"2004","author":"Tuteja","year":"2004","journal-title":"J. Biomed. Biotechnol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3233\/JAD-121786","article-title":"Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion","volume":"34","author":"Won","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"key":"B110","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1304697\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T06:58:13Z","timestamp":1702018693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1304697\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":110,"alternative-id":["10.3389\/fphar.2023.1304697"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1304697","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"article-number":"1304697"}}